HUNTINGTON NATIONAL BANK - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 117 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10.0%10.0%0.00%
Q2 2023$10.0%10.0%0.00%
Q1 2023$10.0%10.0%0.00%
Q4 2022$110.0%0.00%
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$010.0%0.00%
Q3 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$010.0%0.00%
Q4 2020$010.0%0.00%
Q3 2020$010.0%0.00%
Q2 2020$010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.0%0.00%
Q3 2019$010.0%0.00%
Q2 2019$010.0%0.00%
Q4 2018$010.0%0.00%
Q3 2018$0
-100.0%
1
-100.0%
0.00%
Q1 2016$11,0000.0%2,5900.0%0.00%
Q1 2015$11,000
+22.2%
2,5900.0%0.00%
Q4 2014$9,000
-96.4%
2,590
-93.5%
0.00%
-100.0%
Q1 2014$252,000
+140.0%
40,000
+100.0%
0.01%
+66.7%
Q3 2013$105,000
-54.1%
20,000
-32.7%
0.00%
-57.1%
Q2 2013$229,000
-6.1%
29,7000.0%0.01%
-12.5%
Q1 2013$244,00029,7000.01%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Camber Capital Management LP 7,500,000$34,800,0002.37%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,983,710$32,404,0001.08%
DAFNA Capital Management LLC 189,000$877,0000.74%
Lyons Wealth Management, LLC. 56,665$264,0000.30%
Telemetry Investments, L.L.C. 110,000$510,0000.23%
Callan Capital, LLC 232,000$1,076,0000.23%
OXFORD ASSET MANAGEMENT LLP 968,446$4,494,0000.12%
FEDERATED HERMES, INC. 5,641,200$26,175,0000.08%
HRT FINANCIAL LP 31,973$148,0000.07%
WELLINGTON MANAGEMENT GROUP LLP 33,885,551$157,230,0000.04%
View complete list of ARENA PHARMACEUTICALS INC shareholders